Pancreatic Cancer Research

ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years

Li Ren

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0001-6623-4673; OpenAlex author ID A5058758593. Sources: OpenAlex.

Their work

Papers
1 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2024: 1 paper

Papers 1

  1. KLF15 suppresses stemness of pancreatic cancer by decreasing USP21-mediated Nanog stability. Last author DOI 10.1007/s00018-024-05442-6↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Duo Zuo · 1 shared paper, 2024 · strength 0.20
  2. Meng Wang · 1 shared paper, 2024 · strength 0.20
  3. Lu Qiao · 1 shared paper, 2024 · strength 0.20
  4. Wenna Jiang · 1 shared paper, 2024 · strength 0.20
  5. Tianxing Zhou · 1 shared paper, 2024 · strength 0.20
  6. Jing Liu · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.